Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial

المؤلفون المشاركون

Shikora, S.
Sarwer, David B.
Apovian, Caroline M.
Anvari, Mehran
Gibbons, Robert D.
Miller, Christopher J.
Sarr, Michael G.
Wolfe, Bruce
Billington, C. J.
Tweden, K. S.
Knudson, M. B.
Ikramuddin, Sayeed

المصدر

Journal of Obesity

العدد

المجلد 2015، العدد 2015 (31 ديسمبر/كانون الأول 2015)، ص ص. 1-8، 8ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2015-07-12

دولة النشر

مصر

عدد الصفحات

8

التخصصات الرئيسية

الطب البشري

الملخص EN

Background/Objectives.

Vagal block therapy (vBloc) is effective for moderate to severe obesity at one year.

Subjects/Methods.

The ReCharge trial is a double-blind, randomized controlled clinical trial of 239 participants with body mass index (BMI) of 40 to 45 kg/m or 35 to 40 kg/m with one or more obesity-related conditions.

Interventions were implantation of either vBloc or Sham devices and weight management counseling.

Mixed models assessed percent excess weight loss (%EWL) and total weight loss (%TWL) in intent-to-treat analyses.

At 18 months, 142 (88%) vBloc and 64 (83%) Sham patients remained enrolled in the study.

Results.

18-month weight loss was 23% EWL (8.8% TWL) for vBloc and 10% EWL (3.8% TWL) for Sham (P<0.0001).

vBloc patients largely maintained 12-month weight loss of 26% EWL (9.7% TWL).

Sham regained over 40% of the 17% EWL (6.4% TWL) by 18 months.

Most weight regain preceded unblinding.

Common adverse events of vBloc through 18 months were heartburn/dyspepsia and abdominal pain; 98% of events were reported as mild or moderate and 79% had resolved.

Conclusions.

Weight loss with vBloc was sustained through 18 months, while Sham regained weight between 12 and 18 months.

vBloc is effective with a low rate of serious complications.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Shikora, S.& Wolfe, Bruce& Apovian, Caroline M.& Anvari, Mehran& Sarwer, David B.& Gibbons, Robert D.…[et al.]. 2015. Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial. Journal of Obesity،Vol. 2015, no. 2015, pp.1-8.
https://search.emarefa.net/detail/BIM-1069608

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Shikora, S.…[et al.]. Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial. Journal of Obesity No. 2015 (2015), pp.1-8.
https://search.emarefa.net/detail/BIM-1069608

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Shikora, S.& Wolfe, Bruce& Apovian, Caroline M.& Anvari, Mehran& Sarwer, David B.& Gibbons, Robert D.…[et al.]. Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial. Journal of Obesity. 2015. Vol. 2015, no. 2015, pp.1-8.
https://search.emarefa.net/detail/BIM-1069608

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1069608